BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36449008)

  • 41. Solid-Phase Extraction and Enhanced Amplification-Free Detection of Pathogens Integrated by Dual-Functional CRISPR-Cas12a.
    Tian Z; Yan H; Zeng Y
    medRxiv; 2023 Apr; ():. PubMed ID: 37162995
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel methods for the rapid and sensitive detection of Nipah virus based on a CRISPR/Cas12a system.
    Yang X; Xu K; Li S; Zhang J; Xie Y; Lou Y; Xiao X
    Analyst; 2024 Apr; 149(9):2586-2593. PubMed ID: 38497408
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Assessing the time dependence of prognostic values of cytology and human papillomavirus testing in cervical cancer screening.
    Isidean SD; Wang Y; Mayrand MH; Ratnam S; Coutlée F; Franco EL; Abrahamowicz M;
    Int J Cancer; 2019 May; 144(10):2408-2418. PubMed ID: 30411802
    [TBL] [Abstract][Full Text] [Related]  

  • 44. DNA methylation marker for the triage of hrHPV positive women in cervical cancer screening: Real-world evidence in Taiwan.
    Chang CL; Ho SC; Su YF; Juan YC; Huang CY; Chao AS; Hsu ZS; Chang CF; Fwu CW; Chang TC
    Gynecol Oncol; 2021 May; 161(2):429-435. PubMed ID: 33757653
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detection assay for HPV16 and HPV18 by loop‑mediated isothermal amplification with lateral flow dipstick tests.
    Kumvongpin R; Jearanaikoon P; Wilailuckana C; Sae-Ung N; Prasongdee P; Daduang S; Wongsena M; Boonsiri P; Kiatpathomchai W; Swangvaree SS; Sandee A; Daduang J
    Mol Med Rep; 2017 May; 15(5):3203-3209. PubMed ID: 28339040
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Coupling CRISPR/Cas12a and Recombinase Polymerase Amplification on a Stand-Alone Microfluidics Platform for Fast and Parallel Nucleic Acid Detection.
    Zhou H; Xu Z; He L; Wang Z; Zhang T; Hu T; Huang F; Chen D; Li Y; Yang Y; Huang X
    Anal Chem; 2023 Feb; 95(6):3379-3389. PubMed ID: 36735954
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A CRISPR Test for Detection of Circulating Nuclei Acids.
    Tsou JH; Leng Q; Jiang F
    Transl Oncol; 2019 Dec; 12(12):1566-1573. PubMed ID: 31634698
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of a Newly Developed HPV Genotyping Assay (Mojin HPV Kit) with Cobas 4800 HPV Test for Detection of High-Risk HPV in Specimens Collected in SurePath Solution.
    Yang WW; Wang ZG; Chen GF; Shi JF; Chen J; Ma QH; Zhou J; Mao XD; Liu C; Yao XM
    Clin Lab; 2018 Mar; 64(3):387-391. PubMed ID: 29739098
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of the management of Hr-HPV+/PapTest- women: results at 1-year recall.
    Chiappetta C; Puggioni C; Lendaro E; Cacciotti J; Zaralli R; Migliore G; Bellardini P; Petrozza V; Della Rocca C; Di Cristofano C
    Int J Clin Exp Pathol; 2015; 8(12):16089-96. PubMed ID: 26884886
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dynamic Aqueous Multiphase Reaction System for One-Pot CRISPR-Cas12a-Based Ultrasensitive and Quantitative Molecular Diagnosis.
    Yin K; Ding X; Li Z; Zhao H; Cooper K; Liu C
    Anal Chem; 2020 Jun; 92(12):8561-8568. PubMed ID: 32390420
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Primary screening for cervical cancer based on high-risk human papillomavirus (HPV) detection and HPV 16 and HPV 18 genotyping, in comparison to cytology.
    Agorastos T; Chatzistamatiou K; Katsamagkas T; Koliopoulos G; Daponte A; Constantinidis T; Constantinidis TC;
    PLoS One; 2015; 10(3):e0119755. PubMed ID: 25793281
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of human papillomavirus genotyping and cytology triage, COMPACT Study: Design, methods and baseline results in 14 642 women.
    Aoyama-Kikawa S; Fujita H; Hanley SJB; Kasamo M; Kikuchi K; Torigoe T; Matsuno Y; Tamakoshi A; Sasaki T; Matsuura M; Kato Y; Dong P; Watari H; Saito T; Sengoku K; Sakuragi N
    Cancer Sci; 2018 Jun; 109(6):2003-2012. PubMed ID: 29660849
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Zinc finger nucleases targeting the human papillomavirus E7 oncogene induce E7 disruption and a transformed phenotype in HPV16/18-positive cervical cancer cells.
    Ding W; Hu Z; Zhu D; Jiang X; Yu L; Wang X; Zhang C; Wang L; Ji T; Li K; He D; Xia X; Liu D; Zhou J; Ma D; Wang H
    Clin Cancer Res; 2014 Dec; 20(24):6495-503. PubMed ID: 25336692
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The performance of human papillomavirus DNA detection with type 16/18 genotyping by hybrid capture in primary test of cervical cancer screening: a cross-sectional study in 10,669 Chinese women.
    Zhao X; Wu Q; Wang X; Fu Y; Zhang X; Tian X; Cheng B; Lu B; Yu X; Lan S; Lu W; Ma D; Cheng X; Xie X
    Clin Microbiol Infect; 2018 Dec; 24(12):1322-1327. PubMed ID: 29518562
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of Abbott RealTime High Risk HPV and Hybrid Capture 2 for the detection of high-risk HPV DNA in a referral population setting.
    Venturoli S; Leo E; Nocera M; Barbieri D; Cricca M; Costa S; Santini D; Zerbini M
    J Clin Virol; 2012 Feb; 53(2):121-4. PubMed ID: 22115872
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HPV16 and HPV18 genotyping in cervical cancer screening.
    Ronco G; Franceschi S; Segnan N
    Lancet Oncol; 2011 Sep; 12(9):831-2. PubMed ID: 21865085
    [No Abstract]   [Full Text] [Related]  

  • 57. CRISPR-Cas12a-enhanced mass spectrometric DNA nanomachine for HPV-16 detection in human serum.
    Hu Y; Liu L; Wang C; Zhou J; Liu R; Lv Y
    Chem Commun (Camb); 2024 Jan; 60(8):976-979. PubMed ID: 38165777
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The reliability of high-risk human papillomavirus detection by Aptima HPV assay in women with ASC-US cytology.
    Castle PE; Reid J; Dockter J; Getman D
    J Clin Virol; 2015 Aug; 69():52-5. PubMed ID: 26209379
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Validation of a Human Papillomavirus (HPV) DNA Cervical Screening Test That Provides Expanded HPV Typing.
    Demarco M; Carter-Pokras O; Hyun N; Castle PE; He X; Dallal CM; Chen J; Gage JC; Befano B; Fetterman B; Lorey T; Poitras N; Raine-Bennett TR; Wentzensen N; Schiffman M
    J Clin Microbiol; 2018 May; 56(5):. PubMed ID: 29491018
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HPV16 and HPV18 genotyping triage in young women with borderline cytology or mild dyskaryosis: effect of age on genotype-specific risk of high-grade CIN.
    McKenna M; McMenamin M; McDowell A
    Cytopathology; 2016 Aug; 27(4):261-8. PubMed ID: 26873051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.